CXCL8 and cancer: Patients with tumors at advanced clinical stages (stages III and IV; p < 0.001) and lymph node metastasis (p < 0.001) expressed higher levels of IL-6 and IL-8 double-positive TAMs, suggesting that IL-6 and IL-8 double-positive TAMs are related to cancer progression.